Strohbehn GW - Search Results

1

Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts.

Jiang CY, Strohbehn GW, Dedinsky RM, Raupp SM, Pannecouk BM, Yentz SE, Ramnath N. Jiang CY, et al. Among authors: strohbehn gw. JCO Oncol Pract. 2021 Sep;17(9):e1362-e1374. doi: 10.1200/OP.21.00317. Epub 2021 Aug 18. JCO Oncol Pract. 2021. PMID: 34406817

2

Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer.

Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Qin A, Yentz S, Ramnath N, Green MD. Bryant AK, et al. Among authors: strohbehn gw. Lung Cancer. 2022 Jan;163:35-41. doi: 10.1016/j.lungcan.2021.11.021. Epub 2021 Dec 2. Lung Cancer. 2022. PMID: 34896803 Free PMC article.

3

Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer.

Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Daniel V, Ramnath N, Green MD. Bryant AK, et al. Among authors: strohbehn gw. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):60-65. doi: 10.1016/j.ijrobp.2021.12.176. Epub 2022 Feb 1. Int J Radiat Oncol Biol Phys. 2022. PMID: 35115216 Free PMC article.

4

Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.

Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Sankar K, et al. Among authors: strohbehn gw. Cancers (Basel). 2022 Jan 26;14(3):614. doi: 10.3390/cancers14030614. Cancers (Basel). 2022. PMID: 35158881 Free PMC article.

5

Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab.

Bryant AK, Sankar K, Strohbehn GW, Zhao L, Daniel V, Elliott D, Ramnath N, Green MD. Bryant AK, et al. Among authors: strohbehn gw. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):752-758. doi: 10.1016/j.ijrobp.2022.03.015. Epub 2022 Apr 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 35450753 Free PMC article.

6

De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.

Bryant AK, Sankar K, Zhao L, Strohbehn GW, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Bryant AK, et al. Among authors: strohbehn gw. Eur J Cancer. 2022 Aug;171:55-63. doi: 10.1016/j.ejca.2022.04.033. Epub 2022 Jun 12. Eur J Cancer. 2022. PMID: 35704975 Free PMC article.

7

Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation.

Strohbehn GW, Holleman R, Burns J, Klamerus ML, Kelley MJ, Kerr EA, Ramnath N, Hofer TP. Strohbehn GW, et al. JAMA Oncol. 2022 Nov 1;8(11):1663-1667. doi: 10.1001/jamaoncol.2022.4109. JAMA Oncol. 2022. PMID: 36136314 Free PMC article.

8

Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system.

Bryant AK, Lewy JR, Bressler RD, Chopra Z, Gyori DJ, Bazzell BG, Moeller JA, Jacobson SI, Fendrick AM, Kerr EA, Ramnath N, Green MD, Hofer TP, Vaishnav P, Strohbehn GW. Bryant AK, et al. Among authors: strohbehn gw. Lancet Oncol. 2024 Jun;25(6):802-810. doi: 10.1016/S1470-2045(24)00200-6. Lancet Oncol. 2024. PMID: 38821085

9

Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study.

Miller S, Jiang R, Schipper M, Fritsche LG, Strohbehn G, Wallace B, Brinzevich D, Falvello V, McMahon BH, Zamora-Resendiz R, Ramnath N, Dai X, Sankar K, Edwards DM, Allen SG, Yoo S, Crivelli S, Green MD, Bryant AK. Miller S, et al. Lancet Oncol. 2024 Dec;25(12):1666-1676. doi: 10.1016/S1470-2045(24)00528-X. Epub 2024 Nov 14. Lancet Oncol. 2024. PMID: 39551068

10

Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings.

Hsieh PH, Kacew AJ, Dreyer M, Serritella AV, Knoebel RW, Strohbehn GW, Ratain MJ. Hsieh PH, et al. Among authors: strohbehn gw. NPJ Breast Cancer. 2022 Mar 14;8(1):32. doi: 10.1038/s41523-022-00393-2. NPJ Breast Cancer. 2022. PMID: 35288585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters